This inventor holds 1 USPTO granted patent. Top assignee: East China University of Science and Technology. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Mengzhu Xue: Innovator in Pharmaceutical Chemistry
Introduction
Mengzhu Xue is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. His work focuses on inhibitors that target specific proteins involved in various diseases.
Latest Patents
Mengzhu Xue holds a patent for a pteridine ketone derivative, which serves as an inhibitor for EGFR, BLK, and FLT3. This patent outlines the compound's formula and its applications in treating diseases mediated by these proteins. The pharmaceutical composition derived from this compound is designed to aid in the preparation of medicines aimed at inhibiting EGFR, BLK, and FLT3.
Career Highlights
Mengzhu Xue is affiliated with the East China University of Science and Technology, where he conducts research and develops innovative solutions in the pharmaceutical sector. His expertise in chemistry and drug development has positioned him as a key figure in his field.
Collaborations
Mengzhu Xue has worked alongside notable colleagues, including Honglin Li and Yufang Xu. Their collaborative efforts contribute to advancing research and innovation in pharmaceutical applications.
Conclusion
Mengzhu Xue's contributions to pharmaceutical chemistry, particularly through his patent on pteridine ketone derivatives, highlight his role as an influential inventor. His work continues to impact the development of targeted therapies for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile